Study ID
|
Number of participants
|
Time; pathway group (minutes)
|
Time; control group (minutes)
|
P value
|
---|
Carstensen et al. 2007[21]
|
P N=108,
|
MD=154 (IQR 120-233)
|
MD= 249 (IQR 184-405)
|
P<0.001
|
C N=193
|
Bång et al. 2008[23]
|
P N=115,
|
MD=184
|
MD=238
|
P<0.02
|
C N=66
|
(IQR NR)
|
(IQR NR)
|
Dorsch et al. 2008[22]
|
P N=172
|
MD=105
|
MD=143
|
P<0.001
|
C N=215
|
(IQR NR)
|
(IQR NR)
|
Majumder et al. 2011[25]
|
P N=200
|
MD=106 (IQR 91-132)
|
MD=130 (IQR 103-164)
|
p<0.005
|
C N=161
|
Cheskes et al. 2011[26]
|
P N=80
|
MD=70 (IQR 24)
|
MD=107 (IQR 30)
|
P<0.001
|
C N=95
|
Bagai et al. 2013a[27]
|
P N=1316
|
MD=68 (IQR 54-85)
|
MD=88 (IQR 73-106)
|
P<0.001
|
C N=11265
|
Bagai et al. 2013b[28]
|
P N=28
|
MD=75 (IQR 59-93)
|
MD=90 (IQR 76-109)
|
P<0.001
|
C N=1401
|
- N= Numbers.
- P= Pathway.
- C= Control.
- MD= Median.
- IQR= Interquartile range.
- NR= Not reported.
- Symptom onset to balloon time.